TEMPUS
"TEMPUS" is a word and design mark owned by Tempus AI, Inc., filed at the USPTO on June 30, 2023. It is registered and covers classes 9, 42 and 44.
- Status
- Registered
- Since February 10, 2026
- Filed
- June 30, 2023
- Registered
- February 10, 2026
- Expires
- Not recorded
- Application no.
- 98067096
- Registration no.
- 8137890
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word and design
- 3 classes
Who owns TEMPUS
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Tempus AI, Inc.
TEM · Chicago, United States
Representative
Amanda H. Wilcox
Taft Stettinius & Hollister LLP
What the mark covers
The products and services TEMPUS is filed for, grouped by Nice class.
Downloadable and recorded computer software using artificial intelligence for machine learning to support clinical data platforms for diagnostics in the fields of cardiology; downloadable and recorded computer software using artificial intelligence for machine learning for supporting clinical data platforms for cardiac diagnostics and electrophysiology
Platform as a service (PAAS) featuring computer software platforms for medical access to patient health information; Providing a web site featuring technology that enables users to access patient health information; Software as a service (SAAS) services featuring software for medical access to patient health information; Platform as a service (PaaS) featuring computer software platforms for voice command and recognition software, speech to text conversion software, and voice-enabled software applications for information management in the field of electronic health records relating to cardiology; Providing temporary use of online non-downloadable computer software for analyzing health information in support of making clinical decisions in the medical field; Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for health information analysis in support of making clinical decisions in the medical field; Providing a web site featuring technology that enables users to use artificial intelligence for health information analysis in support of making clinical decisions in the medical field; Software as a service (SAAS) services featuring software using artificial intelligence for health information analysis in support of making clinical decisions in the medical field; Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for cardiology health information analysis in support of making clinical decisions in the medical field; Providing a web site featuring technology that enables users to use artificial intelligence for cardiology health information analysis in support of making clinical decisions in the medical field; Software as a service (SAAS) services featuring software using artificial intelligence for cardiology health information analysis in support of making clinical decisions in the medical field; Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for analyzing electrocardiographs and electrocardiograms in support of making clinical decisions in the medical field; Providing a web site featuring technology that enables users to use artificial intelligence for analyzing electrocardiographs and electrocardiograms in support of making clinical decisions in the medical field; Software as a service (SAAS) services featuring software using artificial intelligence for analyzing electrocardiographs and electrocardiograms in support of making clinical decisions in the medical field; Medical research; Software as a Service (SaaS) services featuring software for the review and analysis of medical images in the fields of radiology and pathology that provides actionable insights to add clinical value, improve diagnostic decision making, efficiency, and productivity, in the fields of cardiology; medical and scientific research in the field of cardiology; medical and scientific research and development services in the field of cardiology and electrophysiology; software development for cardiac diagnostics and cardiology and electrophysiology; platform as a service (PAAS) featuring computer software platforms for operating cardiology and electrophysiology clinical decision support; software as a service (SAAS) services featuring software for cardiology and electrophysiology clinical decision support; software as a service (SAAS) services featuring artificial intelligence and machine learning-enabled computer software supporting clinical data platforms for use in the fields of cardiology and electrophysiology; platform as a service (PAAS) featuring computer software platforms employing artificial intelligence and machine learning-enabled computer software supporting clinical data platforms for use in the fields of cardiology and electrophysiology; providing a website featuring on-line non-downloadable software that enables users to analyze genome sequences for disease assessment, prediction of medical and clinical outcomes, medical and clinical research, and drug development; computer system design for use in electrophysiology and cardiology diagnostics and testing; software development for diagnostics and medical, clinical and research testing in the fields of electrophysiology and cardiology diagnostics and testing; software as a service (SAAS) services featuring software for clinical decision support in the fields of electrophysiology and cardiology, diagnostics and testing; platform as a service (PAAS) featuring computer software platforms for clinical decision support in the fields of electrophysiology and cardiology diagnostics and testing
Medical services; providing an Internet website portal featuring patient health information in the fields of electrophysiology and cardiology; medical services in the fields of cardiology and electrophysiology diagnostics and testing
What has happened so far
Steps recorded by the USPTO, newest first.
- Teas withdrawal of attorney received-firm retains
- Teas change of correspondence received
- Attorney/dom.rep.revoked and/or appointed
- Teas revoke/app/change addr of atty/dom rep received
- Notice of registration confirmation emailed
- Registered-principal register
- Notice of acceptance of statement of use e-mailed
- Allowed principal register - sou accepted
- Statement of use processing complete
- Case assigned to intent to use paralegal
10 earlier steps on the official record.
Oppositions and cancellations
Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.
About TEMPUS
Who owns the trademark "TEMPUS"?
The USPTO trademark "TEMPUS" (application 98067096) is owned by Tempus AI, Inc.
What is the status of "TEMPUS"?
Its status at the USPTO is: registered.
When was "TEMPUS" registered?
It was registered on February 10, 2026.
Get this data via the API
Everything on this page comes from the Signa API. Pull TEMPUS and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2bdd-fa9c-71dc-97d9-00a747c88543
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2bdd-fa9c-71dc-97d9-00a747c88543",
"object": "trademark",
"mark_text": "TEMPUS",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "98067096",
"filing_date": "2023-06-30",
"nice_classes": [
9,
42,
44
],
"owners": [
{
"name": "TEMPUS AI, INC.",
"entity_id": "ent_019ebba8-5c25-7389-b2bd-4d269a5cdfde"
}
]
}